Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hong Luo
Observed names:
HONG LUO,
Luo, Hong
Institution:
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0001-8699-3856
Observed ORCID:
0000-0001-8699-3856
OpenAlex ID:
A5003009751
An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2023
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
·
Cancer Research
·
22
Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4
2025
·
Zhangyuan Gu
, Fugui Ye
, et al.
·
Journal of Biomedical Science
·
20
Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer
2024
·
Bo-Yue Han
, Chao Chen
, et al.
·
Cancer Letters
·
15
Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival
2023
·
XIANGCHEN HAN
, BOYUE HAN
, et al.
·
Cancers
·
11
PDF
Multiomics and single‐cell sequencings reveal the specific biological characteristics of low Ki‐67 triple‐negative breast cancer
2024
·
Boyue Han
, Xiangchen Han
, et al.
·
Cancer Innovation
·
3
PDF
168 The Mutational Landscape of the PI3K/AKT Pathway in Invasive Lobular Carcinoma and Its Association with Clinicopathological Features
2026
·
Ming Li
, Hong Lv
, et al.
·
Laboratory Investigation
Table S1 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Table S4-6 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Figure S1-9 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S2 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S3 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S7 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S8 from An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
2025
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Table S4-6 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S1 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Supplementary Figure S1-9 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S7 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S2 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S3 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S8 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Data from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S3 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S7 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S1 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Table S8 from An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breast cancer progression
2024
·
Xun-Xi Lu
, Wen-Xiao Yang
, et al.
Show more works
View as search
Works count:
49
Citation count:
71
H-index:
4
I10-index:
4
Year
Topic
Type